400 West Cummings Park |
Dinesh Patel, chairman and CEO |
Overview Silico Insights Inc. is bioinformatics company that has designed a technology platform to aid in expression/proteomic analysis, pharmacogenomics, pharmacovigilance (safety and post-marketing surveillance) and clinical data mining. The company’s i-Sight Discovery platform provides analytical reports of data, outcome-driven patterns stored in a “knowledge repository” for re-use, and customized reports with interactive graphics. i-Sight Enterprise is designed to gather data from disparate sources, internal and external, and create real-time composite performance patterns. i-Sight Domain captures relevant information from various public domain databases of drug safety and treatment data.
Partners Silico Insights and Ashni Naturaceuticals, of Salt Lake City, announced in March 2001 a collaboration to apply informatics techniques to identify regulatory and post-translational pathways from genomics and proteomics data. The companies filed a joint patent application concerning the collaboration. The company’s customers include pharmaceutical and biotechnology companies and health care providers. |